Abstract. This document updates and expands the initial Infectious Diseases Society of America (IDSA) Fever and Neutropenia Guideline that. Risk of febrile neutropenia (FN) should be systematically assessed (in consultation with infectious disease specialists as needed), including. Febrile neutropenia (FN) is a serious complication of cancer chemotherapy that The Infectious Diseases Society of America (IDSA), National.
|Published (Last):||7 March 2011|
|PDF File Size:||14.54 Mb|
|ePub File Size:||13.82 Mb|
|Price:||Free* [*Free Regsitration Required]|
This antifungal prophylactic benefit has not been established for post-remission consolidation therapy for acute leukemia and is not routinely recommended. In addition, high-risk patients may have clinically relevant comorbidities such as hypotension, pneumonia, new onset of abdominal pain, renal or hepatic insufficiency, or neurological changes.
Additional factors that increase the risk of complications for patients with FN following cancer chemotherapy are summarized in Table 2. If methicillin-resistant Staphylococcus aureus is suspected, the initial antibiotic regimen can be modified to include vancomycin, daptomycin, or linezolid.
Viridans group streptococcal infections among children with cancer and the importance of emerging antibiotic resistance.
Emergence of MRSA in positive blood cultures from patients with febrile neutropenia-a cause for concern.
Hand hygiene, maximal sterile barrier precautions, and cutaneous antisepsis with chlorhexidine during CVC insertion are recommended for all CVC insertions A- – I. Because clinical manifestations are nonspecific in the early stages of neytropenia infection, the diagnosis of invasive fungal infection is especially difficult.
The test should be used only for patients at risk for Aspergillus infection. Cultures febrioe be obtained from suspected sites of infection for appropriate microbiological testing prior to empirical antimicrobial therapy.
Guidelines in the Management of Febrile Neutropenia for Clinical Practice
However, family members of patients with cancer may receive the live attenuated influenza vaccination. Patients who do not defervesce after 2 to 3 days of an initial, empirical, broad-spectrum antibiotic regimen should be re-evaluated and considered as candidates for inpatient treatment. In the absence of effector cells, primarily neutrophils, signs and symptoms of inflammation may be lacking and rapid progression of invasive bacterial infections may occur, so antibiotics are a life-saving measure in this situation.
Fluconazole prophylaxis is effective in reducing the risk of Candida infections in neutropenic patients, is well tolerated, and is available in both oral and IV formulations [ ferile, — ]. Transthoracic echocardiogram may be the only modality available for assessment of valves, because transesophageal echocardiogram may be delayed until resolution neuttopenia neutropenia and concurrent thrombocytopenia. Broader decisions about when and how to modify antimicrobial coverage during the course of neutropenia should iddsa based on the risk category low or highthe fehrile of fever in documented infections, and a clinical judgment about whether the patient is responding to the initial regimen.
Guidelines in the Management of Febrile Neutropenia for Clinical Practice
However, as with other hospitalized patients, when contact with body fluids is anticipated, standard barrier precautions should be followed [ ]. These agents should be considered for specific clinical indications, including suspected catheter-related infection, skin and soft-tissue infection, pneumonia, or hemodynamic instability.
In the setting of an influenza outbreak, aggressive infection control measures should be instituted to halt further nosocomial spread [ ]. The guideline recommendations were based on the review of evidence by the Expert Panel. Elevations of creatine kinase level may be seen in patients who receive daptomycin treatment.
Neutroopenia Panel recommends that either the clinical judgment criteria that have been based upon data derived from published neutropfnia trials or the MASCC assessment tool can be used to stratify risk for patients presenting with fever and neutropenia. The recommendations are derived from well-tested patterns of clinical practice that have emerged from cancer therapy clinical neutropenix modifications of these recommendations are based upon careful review of data from recent scientific publications and peer-reviewed information whenever possible.
Years of experience have proven this approach to be safe and effective. Risk stratification is a recommended starting point for managing patients with fever and neutropenia. It is important to realize that guidelines cannot always account for individual variation among patients. Plants and dried or fresh flowers should not be allowed in the rooms of hospitalized neutropenic patients, because molds, including Aspergillus and Fusarium species, have been isolated from the soil of potted ornamental plants eg, cactithe surfaces of dried flower arrangements, and fresh flowers [ ].
Fever and Neutropenia in Adults with Cancer
A chest radiograph is indicated for patients with respiratory signs or symptoms A-III. Cancer centers caring for patients at high-risk for invasive mold infection such as HSCT recipients or patients with leukemia should routinely monitor the number of aspergillosis cases. All members of the Panel complied with the IDSA policy on conflicts of interest, which requires disclosure of any financial or other interest that might be construed as constituting an actual, potential, or apparent conflict.
Low-risk patients are neuttropenia with neutropenia expected to resolve within 7 days and no active medical co-morbidity, as well as stable and adequate hepatic neutroprnia and renal function.
Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: Studies have suggested that a CVC blood culture that becomes positive at least min earlier than a simultaneously drawn peripheral vein blood culture indicates that the catheter is likely to be the source of infection [— ].
Risk assessment and treatment of low-risk patients with febrile neutropenia. In cases in which the catheter must be retained, it is prudent to prolong the antimicrobial IV systemic therapy, particularly in the case of S. This should be kept in mind when evaluating neutropenic patients who remain febrile after the initiation of empirical antibacterials.
Outpatient Parenteral Antimicrobial Therapy. These low-risk features are most commonly found among patients with solid tumors, although not exclusively so. High-risk patient with fever after 4 days of empirical antibiotics. It is based on the principle that, although antibiotics are required to contain an occult infection during neutropenia, the return of adequate effector cells is necessary to protect the patient.
Addition of a gram-positive active agent to fluoroquinolone prophylaxis is generally not recommended A-I.
Physician Leadership of Population Health Services. Additionally, patient history should be analyzed for past positive microbiology records, specifically the presence of antibiotic-resistant organisms or bacteremia.
Six new or updated meta-analyses and six new primary studies were added to the updated systematic review.
Household pets that might be brought to the hospital for pet therapy should not be allowed onto the ward where patients with neutropenia are housed.
Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancy.